Metraipolis › archive › dc_31e579ae5cb4

Overcoming barriers to off-patent drug repurposing: a lifecycle-based policy solutions — Europe PMC PMID:41208860

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41208860
DOI
10.3389/fphar.2025.1670845
License (as archived)
solo-consultazione
Archived
2026-10-06T08:06:25.046Z
SHA-256 of the archived text
7bbf095aed83cf2b22185cf903a6545685662762c805ac0d33d81af4aa68c6e3
Stable URL of this page
https://metraipolis.com/documento/dc_31e579ae5cb4

How to cite

Overcoming barriers to off-patent drug repurposing: a lifecycle-based policy solutions — Europe PMC PMID:41208860 — Europe PMC (en), https://europepmc.org/article/MED/41208860 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_31e579ae5cb4 (Metraipolis archive dc_31e579ae5cb4, sha256 7bbf095aed83cf2b22185cf903a6545685662762c805ac0d33d81af4aa68c6e3)
BibTeX
@misc{dc31e579ae5cb4,
  title = {Overcoming barriers to off-patent drug repurposing: a lifecycle-based policy solutions — Europe PMC PMID:41208860},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41208860},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_31e579ae5cb4; sha256 7bbf095aed83cf2b22185cf903a6545685662762c805ac0d33d81af4aa68c6e3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41208860. Agents can read the archived copy with the MCP tool read_document.